← Browse by Condition

Medical Condition

hiv

Total Trials

38

Recruiting Now

38

Trial Phases

Phase 1, Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for hiv sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hiv Clinical Trials

How many clinical trials are currently recruiting for hiv?

ClinicalMetric currently tracks 38 actively recruiting clinical trials for hiv, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 38. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for hiv?

hiv research spans Phase 1 (1 trial), Phase 2 (4 trials), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a hiv clinical trial?

Eligibility criteria for hiv trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

1

Phase 2

4

Phase 3

1

Phase 4

2

Top Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) 2 trials

Yale University 2 trials

Boston University 2 trials

Massachusetts General Hospital 2 trials

Johns Hopkins University 2 trials

Recruiting Clinical Trials

NCT07390955 Phase 1

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

United States, Peru,...

National Institute of Allergy ...

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

Tulane University

Reaching the Last 20% (the Pamoja Kwa Afya Study)

PRIDE III Prison Interventions and HIV Prevention Collaboration

United States, Georg...

Yale University

HIV, Equity, and Addiction Training (HEAT) Program

University of Alabama at Birmi...

NCT04875819 Phase 4

Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV

Thomas Benfield

Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon

Institut de Recherche pour le ...

Enhanced Problem-solving Therapy and HIV Engagement Support to Improve Perinatal Mental Health & HIV Outcomes in Malawi

University of North Carolina, ...

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

University of Texas Southweste...

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

Côte d’Ivoire, Kenya

MagIA Diagnostics

Gathering Records to Evaluate Antiretroviral Treatment-Zambia (GREAT )

Boston University

Human Immunodeficiency Virus (HIV) Food Insecurities

Wake Forest University Health ...

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

Boston University

Improving Engagement in HIV and Cancer Care in Zimbabwe

Fred Hutchinson Cancer Center

Gathering Online for Dialogue and Discussion to Enhance Social Support

RTI International

The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

University of California, San ...

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Institute of Tropical Medicine...

NCT05443555 Phase 2

Gabapentin to Reduce Alcohol and Improve Viral Load Suppression

Boston Medical Center

NCT07199335 Phase 4

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Massachusetts General Hospital

Viral Load in Blood and Lymph Tissues in People Living With HIV

National Institute of Allergy ...

PrEP Readiness Interventions for Sustained Motivation (PRISM)

Florida International Universi...

NCT06034938 Phase 2

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

University Hospital, Caen

Implementing Depression and Adherence Treatment

United States, South...

University of Miami

Wellness Intervention for Smoking and HIV

University of Arizona

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

United States, South...

Boston University Charles Rive...

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries

Armenia, Georgia, Ta...

Médecins du Monde

NCT06497465 Phase 3

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Johns Hopkins University

Stress and Pain in People Living With HIV

Yale University

Prevention ICONA Dedicated Ensemble

Fondazione ICONA

A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression

University of Florida

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

University Hospital, Ghent

Universal Basic Income and Structural Racism in the US South: HIV Care

University of Arkansas

Improving HIV Care Continuum Outcomes Among Formerly Incarcerated Individuals Through Critical Time Legal Interventions

University of Central Florida

NCT05514899 Phase 2

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

University of California, San ...

Reduce Tobacco Use in People Living With HIV in Switzerland

University Hospital, Basel, Sw...

NCT05570812 Phase 2

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Massachusetts General Hospital

The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study

Johns Hopkins University

LA PrEP Impact and Cost-effectiveness (TEAMS)

Institute of HIV Research and ...

Related Conditions

depression (4) syphilis (2) substance use disorders (2) chlamydia (1) gonorrhea (1) opioid use (1) opioid use disorder (1) stimulant use diagnosis (1) meningococcal infections (1) pneumococcal infections (1) cervical cancer screening (1) depression postpartum (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology